Effects of thiazolidinediones on glucocorticoid-induced insulin resistance and GLUT4 glucose transporter expression in rat skeletal muscle

Keyphrases

• Insulin Resistance 100%
• Glucose Transporter 1 (GLUT1) 100%
• Glucose Transporter 4 (GLUT4) 100%
• Transporter Expression 100%
• Glucocorticoid-induced 100%
• Rat Skeletal muscle 100%
• Pioglitazone 100%
• Thiazolidinediones 100%
• Insulin 75%
• Skeletal muscle 50%
• Soleus muscle 50%
• Dexamethasone Treatment 50%
• 2-Deoxyglucose Uptake 50%
• GLUT4 Expression 50%
• Insulin Sensitivity 25%
• Control Value 25%
• Mechanism of Action 25%
• Additional Treatment 25%
• Glucocorticoid Therapy 25%
• Mode of Action 25%
• Blood Glucose 25%
• Fasting Insulin 25%
• Fasting Plasma Glucose 25%
• Protein Content 25%
• GLUT-4 Protein 25%
• Insulin Responsiveness 25%
• Serum Insulin Levels 25%
• Oral Antihyperglycemic Agents 25%
• Thiazolidine-2,4-dione 25%

Biochemistry, Genetics and Molecular Biology

• Skeletal Muscle 100%
• Insulin Resistance 100%
• GLUT4 100%
• Thiazolidinedione 100%
• Glucocorticoid 100%
• Glucose Transporter 100%
• Pioglitazone 66%
• Dexamethasone 66%
• Upregulation 33%
• 2-Deoxy-D-Glucose 33%
• Animal Model 16%
• Insulin Sensitivity 16%
• Glucose Blood Level 16%
• Glucose Level 16%
• Insulin Level 16%
• Insulin Blood Level 16%
• Protein Content 16%
• Thiazolidine 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Glucocorticoid 100%
• Insulin Resistance 100%
• Glucose Transporter 4 100%
• Thiazolidinedione 100%
• Dexamethasone 66%
• Pioglitazone 66%
• Deoxyglucose 33%
• Glucose Transporter 16%
• Thiazolidine 16%